[go: up one dir, main page]

HUT47267A - Process for production of new pirasoline-derivatives and medical compositions containing them - Google Patents

Process for production of new pirasoline-derivatives and medical compositions containing them

Info

Publication number
HUT47267A
HUT47267A HU883014A HU301488A HUT47267A HU T47267 A HUT47267 A HU T47267A HU 883014 A HU883014 A HU 883014A HU 301488 A HU301488 A HU 301488A HU T47267 A HUT47267 A HU T47267A
Authority
HU
Hungary
Prior art keywords
pirasoline
derivatives
new
production
compositions containing
Prior art date
Application number
HU883014A
Other languages
English (en)
Other versions
HU199825B (en
Inventor
Hiroyuki Yamashita
Makoto Odate
Hajime Iizuka
Hiroshi Kawazura
Yoshio Shiga
Hiroshi Namekawa
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Publication of HUT47267A publication Critical patent/HUT47267A/hu
Publication of HU199825B publication Critical patent/HU199825B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU883014A 1987-06-17 1988-06-10 Process for production of new derivatives of pirasoline and medical compositions containing them HU199825B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14891987 1987-06-17

Publications (2)

Publication Number Publication Date
HUT47267A true HUT47267A (en) 1989-02-28
HU199825B HU199825B (en) 1990-03-28

Family

ID=15463593

Family Applications (2)

Application Number Title Priority Date Filing Date
HU896190A HU202106B (en) 1987-06-17 1988-06-10 Process for producing pharmaceutical compositions containing pyrazolin derivatives
HU883014A HU199825B (en) 1987-06-17 1988-06-10 Process for production of new derivatives of pirasoline and medical compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU896190A HU202106B (en) 1987-06-17 1988-06-10 Process for producing pharmaceutical compositions containing pyrazolin derivatives

Country Status (7)

Country Link
US (2) US4839376A (hu)
EP (1) EP0295695B1 (hu)
KR (1) KR900004413B1 (hu)
CN (1) CN1014245B (hu)
CA (1) CA1311760C (hu)
DE (1) DE3889974T2 (hu)
HU (2) HU202106B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895947A (en) * 1987-12-17 1990-01-23 Mitsui Toatsu Chemicals, Inc. Process for producing 1-acyl-2-pyrazoline derivative
US5089622A (en) * 1988-12-12 1992-02-18 Mitsui Toatsu Chemicals Incorporated (-)-2-pyrazoline compounds and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
US5155126A (en) * 1990-03-20 1992-10-13 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
US5250532A (en) * 1991-04-11 1993-10-05 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides
US5493024A (en) * 1991-04-11 1996-02-20 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides
US5250561A (en) * 1991-08-08 1993-10-05 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors
US5338856A (en) * 1992-08-17 1994-08-16 Dowelanco 3,4-N,trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides
WO2007008529A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc Celullar cholesterol absorption modifiers
CN104030983A (zh) * 2014-03-21 2014-09-10 上海大学 含氟三苯基吡唑衍生物及其制备方法
UY36680A (es) 2015-05-19 2016-12-30 Glaxosmithkline Ip Dev Ltd Amidas heterocíclicas como inhibidores de quinasa
TW201831464A (zh) * 2016-11-18 2018-09-01 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺
CN114524828B (zh) * 2022-02-22 2024-07-09 深圳市儿童医院 一种用于治疗神经重症的噻唑衍生物及其应用
CN114524827B (zh) * 2022-02-22 2024-07-09 深圳市儿童医院 一种用于治疗神经重症的吡唑衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003889A (en) * 1973-06-21 1977-01-18 Sandoz Ltd. 1,3-Diaryl-2-pyrazoline derivatives
US4250185A (en) * 1980-03-10 1981-02-10 Stauffer Chemical Company 1-(3,5-Dichlorobenzoyl)-3-phenylpyrazolines and their use as mildewicides
US4677210A (en) * 1985-06-19 1987-06-30 Rorer Pharmaceutical Corporation 1-arylalkoxy- and 1-arylalkylthioaryl-2-pyrazolines as anti-inflammatory or anti-allergic agents
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
EP0268354A3 (en) * 1986-10-07 1988-06-15 Imperial Chemical Industries Plc Substituted pyrazoline

Also Published As

Publication number Publication date
CN1014245B (zh) 1991-10-09
HU202106B (en) 1991-02-28
CN88103735A (zh) 1988-12-28
EP0295695A2 (en) 1988-12-21
DE3889974D1 (de) 1994-07-14
DE3889974T2 (de) 1994-09-15
EP0295695A3 (en) 1990-06-06
US4839376A (en) 1989-06-13
KR900004413B1 (ko) 1990-06-25
KR890000428A (ko) 1989-03-14
HU199825B (en) 1990-03-28
US4990529A (en) 1991-02-05
CA1311760C (en) 1992-12-22
EP0295695B1 (en) 1994-06-08
HU896190D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
HUT50190A (en) Process for production of n-substituated 1-dezoxinogimiricin and 1-dezoxi-manno-nogimiricin and medical compositions containing them
HUT47561A (en) Process for production of 3-aryloxi-3-substituated propanamids and medical compositions containing them
HUT50151A (en) Process for production of benzo/b/pirans and piranpiridins and medical compositions containing them
HUT47568A (en) Process for production of derivatives of tiazepine and medical compositions containing them
HUT45895A (en) Process for production of serotomin antagonic compounds and medical preparatives containing such compositions
HUT47022A (en) Process for production of medical compositions
HUT46221A (en) Process for production of medical compositions containing alphusosine
HUT46912A (en) Process for production of 1,4-dihydro-piridines and medical preparatives containing such compositions
HUT42953A (en) Process for production of medical compositions
HUT49893A (en) Process for production of new crystallic formation and medical compositions containing it
HUT44794A (en) Process for production of calcitonine-derivatives and medical preparatives containing such compounds
HUT37628A (en) Process for production of acetil-eritromicin-stearat and medical preparatives containing - as reagent - such compounds
HUT45982A (en) Process for production of microlide compositions and medical preparatives containing such compositions
HUT50166A (en) Process for production of substituated 3,4-dihydro-rh-benzopiranes and medical compositions containing them
HUT51247A (en) Process for production of aryl-zyanguananidins and medical compositions containing them
HUT45971A (en) Process for production of new alkon-sulphon-anilid and medical preparatives containing such substances
HUT45979A (en) Process for production of 5-phenil-2-oxasole-derivatives and medical compositions containing such compounds
HUT47267A (en) Process for production of new pirasoline-derivatives and medical compositions containing them
HUT50165A (en) Process for production of alkyl substituated n-benzopiramil lactanes and medical compositions containing them
HUT50167A (en) Process for production of derivatives of tetrasole and medical compositions containing them
HUT47594A (en) Process for production of new derivatives of furanuronic acid and medical compositions containing them
HUT42455A (en) Process for production of derivatives of 5-substituated amino-piramidin and medical compositions containing thereof
HUT49342A (en) Process for production of derivatives of quinoline and medical compositions containing them
HUT48278A (en) Process for production of rhenin-hindering dipeptides and medical preparatives containing them
HUT48579A (en) Process for production of derivatives of pirrolidine and medical preparatives containing these substances

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: MITSUI CHEMICALS, INC., JP

HMM4 Cancellation of final prot. due to non-payment of fee